KRAS and colorectal cancer: In accordance with prior evidence suggesting a functional association between KCNN4 and KRAS signaling in colorectal cancer, our analysis revealed that KCNN4 expression is significantly elevated in KRAS‐mutant PDAC samples compared to wild‐type (Wilcoxon p = 3.5 × 10−16).